Novel fold of VirA, a type III secretion system effector protein from Shigella flexneri

被引:17
作者
Davis, Jamaine [1 ]
Wang, Jiawei [2 ,3 ]
Tropea, Joseph E.
Zhang, Di [4 ]
Dauter, Zbigniew [3 ]
Waugh, David S. [4 ]
Wlodawer, Alexander [1 ]
机构
[1] NCI Frederick, Prot Struct Sect, Macromol Crystallog Lab, Frederick, MD 21702 USA
[2] SAIC Frederick Inc, Basic Res Program, Frederick, MD 21702 USA
[3] NCI, Synchrotron Radiat Res Sect, Macromol Crystallog Lab, Argonne, IL 60439 USA
[4] NCI, Prot Engn Sect, Macromol Crystallog Lab, Frederick, MD 21702 USA
关键词
crystallography; protein crystallization; proteolysis; bacterial virulence; novel fold;
D O I
10.1110/ps.037978.108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
VirA, a secreted effector protein from Shigella sp., has been shown to be necessary for its virulence. It was also reported that VirA might be related to papain-like cysteine proteases and cleave alpha-tubulin, thus facilitating intracellular spreading. We have now determined the crystal structure of VirA at 3.0 angstrom resolution. The shape of the molecule resembles the letter "V,'' with the residues in the N-terminal third of the 45-kDa molecule ( some of which are disordered) forming one clearly identifiable domain, and the remainder of the molecule completing the V-like structure. The fold of VirA is unique and does not resemble that of any known protein, including papain, although its N-terminal domain is topologically similar to cysteine protease inhibitors such as stefin B. Analysis of the sequence conservation between VirA and its Escherichia coli homologs EspG and EspG2 did not result in identification of any putative protease-like active site, leaving open a possibility that the biological function of VirA in Shigella virulence may not involve direct proteolytic activity.
引用
收藏
页码:2167 / 2173
页数:7
相关论文
共 32 条
[21]   Enteropathogenic Escherichia coli type III effectors EspG and EspG2 disrupt the microtubule network of intestinal epithelial cells [J].
Shaw, RK ;
Smollett, K ;
Cleary, J ;
Garmendia, J ;
Straatman-Iwanowska, A ;
Frankel, G ;
Knutton, S .
INFECTION AND IMMUNITY, 2005, 73 (07) :4385-4390
[22]   A short history of SHELX [J].
Sheldrick, George M. .
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2008, 64 :112-122
[23]  
SHELDRICK GM, 2001, XPREP PROGRAM 6 14
[24]   Function and distribution of EspG2, a type III secretion system effector of enteropathogenic Escherichia coli [J].
Smollett, Katherine ;
Shaw, Robert K. ;
Garmendia, Junkal ;
Knutton, Stuart ;
Franke, Gad .
MICROBES AND INFECTION, 2006, 8 (08) :2220-2227
[25]   THE REFINED 2.4A X-RAY CRYSTAL-STRUCTURE OF RECOMBINANT HUMAN STEFIN-B IN COMPLEX WITH THE CYSTEINE PROTEINASE PAPAIN - A NOVEL TYPE OF PROTEINASE-INHIBITOR INTERACTION [J].
STUBBS, MT ;
LABER, B ;
BODE, W ;
HUBER, R ;
JERALA, R ;
LENARCIC, B ;
TURK, V .
EMBO JOURNAL, 1990, 9 (06) :1939-1947
[26]   SOLVE and RESOLVE: Automated structure solution and density modification [J].
Terwilliger, TC .
MACROMOLECULAR CRYSTALLOGRAPHY, PT D, 2003, 374 :22-37
[27]   Automated MAD and MIR structure solution [J].
Terwilliger, TC ;
Berendzen, J .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 1999, 55 :849-861
[28]   Rapid automatic NCS identification using heavy-atom substructures [J].
Terwilliger, TC .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 :2213-2215
[29]   Enteropathogenic Escherichia coli EspG disrupts microtubules and in conjunction with Orf3 enhances perturbation of the tight junction barrier [J].
Tomson, FL ;
Viswanathan, VK ;
Kanack, KJ ;
Kanteti, RP ;
Straub, KV ;
Menet, M ;
Kaper, JB ;
Hecht, G .
MOLECULAR MICROBIOLOGY, 2005, 56 (02) :447-464
[30]  
Tropea Joseph E, 2007, Methods Mol Biol, V363, P1, DOI 10.1007/978-1-59745-209-0_1